These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 28539276)
1. [Expectant therapy versus curettage for retained products of conception after second trimester termination of pregnancy: analysis of outcomes and complications]. Zeng WJ; An SL; Huang H; Huang QT; Li FF; Wang HZ; Cai DC; Gao YF Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):569-574. PubMed ID: 28539276 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Reproductive Outcomes following Retained Products of Conception after Vaginal Delivery versus First-Trimester Abortion. Melcer Y; Smorgick N; Schneider D; Pansky M; Halperin R; Ben-Ami I Gynecol Obstet Invest; 2015; 80(3):206-10. PubMed ID: 26088169 [TBL] [Abstract][Full Text] [Related]
3. Expectant management of retained products of conception following abortion: A retrospective cohort study. Wada Y; Takahashi H; Suzuki H; Ohashi M; Ogoyama M; Nagayama S; Baba Y; Usui R; Suzuki T; Ohkuchi A; Fujiwara H Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():1-5. PubMed ID: 33689917 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic and therapeutic decision-making with transvaginal sonography for first trimester spontaneous abortion, clinically thought to be incomplete or complete. Cetin A; Cetin M Contraception; 1998 Jun; 57(6):393-7. PubMed ID: 9693399 [TBL] [Abstract][Full Text] [Related]
5. Risk factors of retained products of conception after miscarriage or termination with gemeprost in the second trimester of pregnancy: a retrospective case-controlled study in Japanese population. Noguchi T; Shiro M; Nanjo S; Mizoguchi M; Ota N; Mabuchi Y; Yagi S; Minami S; Ino K J Obstet Gynaecol; 2022 Apr; 42(3):501-504. PubMed ID: 34162287 [TBL] [Abstract][Full Text] [Related]
6. Expectant, medical, or surgical treatment of spontaneous abortion in first trimester of pregnancy? A pooled quantitative literature evaluation. Geyman JP; Oliver LM; Sullivan SD J Am Board Fam Pract; 1999; 12(1):55-64. PubMed ID: 10050644 [TBL] [Abstract][Full Text] [Related]
7. Curettage after midtrimester termination of pregnancy. Is it necessary? Lurie S; Appelman Z; Katz Z J Reprod Med; 1991 Nov; 36(11):786-8. PubMed ID: 1765956 [TBL] [Abstract][Full Text] [Related]
8. Ultrasonographic vascularity assessment for predicting future severe hemorrhage in retained products of conception after second-trimester abortion. Akiba N; Iriyama T; Nakayama T; Seyama T; Sayama S; Kumasawa K; Komatsu A; Yabe S; Nagamatsu T; Osuga Y; Fujii T J Matern Fetal Neonatal Med; 2021 Feb; 34(4):562-568. PubMed ID: 31006292 [No Abstract] [Full Text] [Related]
10. Misoprostol treatment vs expectant management in women with early non-viable pregnancy and vaginal bleeding: a pragmatic randomized controlled trial. Fernlund A; Jokubkiene L; Sladkevicius P; Valentin L Ultrasound Obstet Gynecol; 2018 Jan; 51(1):24-32. PubMed ID: 29072372 [TBL] [Abstract][Full Text] [Related]
11. Dilatation and evacuation procedures and second-trimester abortions. The role of physician skill and hospital setting. Cates W; Schulz KF; Grimes DA; Horowitz AJ; Lyon FA; Kravitz FH; Frisch MJ JAMA; 1982 Aug; 248(5):559-63. PubMed ID: 6285012 [TBL] [Abstract][Full Text] [Related]
12. Expectant versus surgical management of first-trimester miscarriage: a randomised controlled study. Al-Ma'ani W; Solomayer EF; Hammadeh M Arch Gynecol Obstet; 2014 May; 289(5):1011-5. PubMed ID: 24240972 [TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive pills as an option for non-surgical management of retained products of conception - a preliminary study. Hershko Klement A; Frederic M; Bentov Y; Chang P; Nayot D; Haas J; Casper RF Gynecol Endocrinol; 2018 Jul; 34(7):609-611. PubMed ID: 29345165 [TBL] [Abstract][Full Text] [Related]
14. Early complications after induced first-trimester abortion. Heisterberg L; Kringelbach M Acta Obstet Gynecol Scand; 1987; 66(3):201-4. PubMed ID: 3661126 [TBL] [Abstract][Full Text] [Related]
15. Uterine curettage following second trimester abortion by extraovular instillation of prostaglandin E2. A prospective-randomized trial. Atad J; Hallak M; Fruchter O; Yshai D; Auslender R; Abramovici H Eur J Obstet Gynecol Reprod Biol; 1999 Aug; 85(2):147-50. PubMed ID: 10584627 [TBL] [Abstract][Full Text] [Related]
16. Hysteroscopic Removal of Retained Products of Conception Implanted Over a Focal Area of Adenomyosis: A Case Report. Alonso L; Nieto L; Carugno J J Minim Invasive Gynecol; 2018; 25(3):382-383. PubMed ID: 28939480 [TBL] [Abstract][Full Text] [Related]
17. Mifepristone-induced abortion and vaginal bleeding in subsequent pregnancy. Liang H; Gao ES; Chen AM; Luo L; Cheng YM; Yuan W Contraception; 2011 Dec; 84(6):609-14. PubMed ID: 22078190 [TBL] [Abstract][Full Text] [Related]
18. Role of transvaginal sonography in the diagnosis of retained products of conception. Ustunyurt E; Kaymak O; Iskender C; Ustunyurt OB; Celik C; Danisman N Arch Gynecol Obstet; 2008 Feb; 277(2):151-4. PubMed ID: 17710427 [TBL] [Abstract][Full Text] [Related]
19. Vaginal misoprostol as medical treatment for first trimester spontaneous miscarriage. Ngai SW; Chan YM; Tang OS; Ho PC Hum Reprod; 2001 Jul; 16(7):1493-6. PubMed ID: 11425836 [TBL] [Abstract][Full Text] [Related]
20. Expectant management versus elective curettage for the treatment of spontaneous abortion. Hurd WW; Whitfield RR; Randolph JF; Kercher ML Fertil Steril; 1997 Oct; 68(4):601-6. PubMed ID: 9341597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]